These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 28719837)
1. Prescription trends and the selection of initial oral antidiabetic agents for patients with newly diagnosed type 2 diabetes: a nationwide study. Liu CH; Chen ST; Chang CH; Chuang LM; Lai MS Public Health; 2017 Nov; 152():20-27. PubMed ID: 28719837 [TBL] [Abstract][Full Text] [Related]
3. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study. Ou HT; Chang KC; Li CY; Wu JS Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study. Chang YC; Chuang LM; Lin JW; Chen ST; Lai MS; Chang CH Diabet Med; 2015 Nov; 32(11):1460-9. PubMed ID: 25970814 [TBL] [Abstract][Full Text] [Related]
5. The prescription pattern of initial treatment for type 2 diabetes in Beijing from 2011 to 2015. Wang X; Cao Y; Wu Y; Yang C; Song J; Tian Y; Wang M; Li M; Wu Y; Hu Y Medicine (Baltimore); 2019 Feb; 98(8):e14370. PubMed ID: 30813137 [TBL] [Abstract][Full Text] [Related]
6. Use of antidiabetic drugs in the U.S., 2003-2012. Hampp C; Borders-Hemphill V; Moeny DG; Wysowski DK Diabetes Care; 2014; 37(5):1367-74. PubMed ID: 24623020 [TBL] [Abstract][Full Text] [Related]
7. Trends in antidiabetic medical treatment from 2005 to 2014 in Taiwan. Chu CH; Hsu CC; Lin SY; Chuang LM; Liu JS; Tu ST J Formos Med Assoc; 2019 Nov; 118 Suppl 2():S74-S82. PubMed ID: 31248659 [TBL] [Abstract][Full Text] [Related]
8. Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study. Ko SH; Kim DJ; Park JH; Park CY; Jung CH; Kwon HS; Park JY; Song KH; Han K; Lee KU; Ko KS; Medicine (Baltimore); 2016 Jul; 95(27):e4018. PubMed ID: 27399082 [TBL] [Abstract][Full Text] [Related]
9. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes. Aquilante CL; Zhang W; McCollum M Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730 [TBL] [Abstract][Full Text] [Related]
10. Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001. Wysowski DK; Armstrong G; Governale L Diabetes Care; 2003 Jun; 26(6):1852-5. PubMed ID: 12766122 [TBL] [Abstract][Full Text] [Related]
11. [Antidiabetic drugs prescription patterns among a group of patients in Colombia]. Machado Alba JE; Moncada Escobar JC; Mesa Escobar G Rev Panam Salud Publica; 2007 Aug; 22(2):124-31. PubMed ID: 17976279 [TBL] [Abstract][Full Text] [Related]
12. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients. del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422 [TBL] [Abstract][Full Text] [Related]
13. Disparity in Guideline-Based Antidiabetic Drugs Prescribing for Type 2 Diabetes Patients in Primary Healthcare Facilities Across China, 2017-2019. Fu M; Gong Z; Zhu Y; Li C; Li H; Shi L; Guan X Pharmacoepidemiol Drug Saf; 2024 Aug; 33(8):e5882. PubMed ID: 39092465 [TBL] [Abstract][Full Text] [Related]
14. Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013. Clemens KK; Liu K; Shariff S; Schernthaner G; Tangri N; Garg AX Diabetes Obes Metab; 2016 Jun; 18(6):607-14. PubMed ID: 26939711 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk associated with acarbose versus metformin as the first-line treatment in patients with type 2 diabetes: a nationwide cohort study. Chang CH; Chang YC; Lin JW; Chen ST; Chuang LM; Lai MS J Clin Endocrinol Metab; 2015 Mar; 100(3):1121-9. PubMed ID: 25555040 [TBL] [Abstract][Full Text] [Related]
16. Keeping up with guideline recommendations: does patient volume matter in diabetes care? Chen YC; Cheng SH; Chen CC Am J Manag Care; 2020 Aug; 26(8):e264-e271. PubMed ID: 32835469 [TBL] [Abstract][Full Text] [Related]
17. The impact of initial antidiabetic agent and use of monitoring agents on prescription costs in newly treated type 2 diabetes: A retrospective cohort analysis. Grimes RT; Bennett K; Canavan R; Tilson L; Henman MC Diabetes Res Clin Pract; 2016 Mar; 113():152-9. PubMed ID: 26810270 [TBL] [Abstract][Full Text] [Related]
18. Initial Therapeutic Choices for Type 2 Diabetes in the Portuguese Sentinel Practice Network. Pinto D; Rodrigues AP; Nunes B Acta Med Port; 2019 May; 32(5):375-380. PubMed ID: 31166898 [TBL] [Abstract][Full Text] [Related]
19. Effects of early medication treatment and metformin use for cancer prevention in diabetes patients: a nationwide sample cohort study in Korea using extended landmark time analysis. Seo HJ; Oh HS Epidemiol Health; 2021; 43():e2021103. PubMed ID: 34922421 [TBL] [Abstract][Full Text] [Related]
20. Trends in the prescription of antidiabetic medications in France: evidence from primary care physicians. Boyc KS; Yurgin N; Lage MJ Adv Ther; 2007; 24(4):803-13. PubMed ID: 17901029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]